Takeda signs $1.7bn AI alliance with Iambic

Takeda has joined forces with Iambic Therapeutics on a multiyear collaboration to use the US biotech's AI-driven, structure-based drug discovery platform to find new therapies for gastrointestinal and inflammatory diseases, as well as cancer.

Read more here.

Previous post
Back to list
Next post